Medical Digest & Congress Report

Michael Gnant have been the Co-Chair of the highly successful, annual St Gallen Breast Cancer Conference in Vienna, and chaired a session about the latest advances of CDK4/6 inhibitor treatment in HR+/HER2− early breast cancer, focusing on risk of recurrence. Video: https://medicaldigest.org/scientific-contents/interview:redefining-risk-recurrence-latest-advances-cdk46-inhibitors-hrher2-early-brea...

Sami Timimi indicated in his presentation at the RCPsych in Scotland Winter Conference that formal psychiatric diagnostic systems should be abolished. In our interview he explains why psychiatric labels do more harm than good. Video: https://medicaldigest.org/scientific-contents/interview:why-there-no-such-thing-psychiatric-diagnosis

Edoardo Ostinelli, Senior Researcher & Deputy Lead of Oxford Precision Psychiatry Lab at the Department of Psychiatry, University of Oxford, UK. He is the first author of a recently published article in Lancet Psychiatry about ADHD in adults. How important is this question? How many patients suffer from the disease? We asked him about the study. Video: https://medicaldigest.org/scientific-cont...

Sven Bölte, professor of child and adolescent psychiatric science at Karolinska Institute, Stockholm, Sweden, renowned expert of neurodevelopmental disorders. He is the first author of a recently published article in Neuroscience & Biobehavioral Reviews about social cognition in autism and ADHD. We asked him about the study. Article: Social cognition in autism and ADHD Video: https://medicaldi...

Mark Jankelow, MSN, PMHNP-BC summarizes his presentation at Real Psychiatry 2025 on bipolar disorder and ADHD and shares his 20 years of experience with treatments. Video: https://medicaldigest.org/scientific-contents/interview:addressing-comorbid-bipolar-disorder-and-adhd

Professor Paul G. Richardson summarizes the most important highlights in the field of Multiple Myeloma treatment after the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:management-multiple-myeloma-ash-2024

Kate Lathrop, MD discuss some of the high impact, clinically relevant, clinical trials that were presented at the San Antonio Breast Cancer Symposium 2024. The studies discussed: - (01:28) Circulating tumor DNA surveillance in ZEST, a randomized, phase 3, double-blind study of niraparib or placebo in patients w/ triple-negative breast cancer or HER2+ BRCA-mutated breast cancer with molecular resid...

Janice Tsang, MD discusses early breast cancer updates at San Antonio Breast Cancer Symposium 2024. Videó: https://medicaldigest.org/scientific-contents/interview:early-breast-cancer-updates

William G. Wierda, MD, PhD discusses current questions and state of the art treatement of chronic lymphocytic leukemia at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:cll-highlights-ash-2024

Josef T. Prchal, MD investigated the genetic basis underlying elevated hemoglobin in Andean natives, Aymara, by using granulocyte transcriptome data from both Aymara and Europeans from La Paz, Bolivia. They found their differentially expressed and spliced genes are associated with inflammatory and HIFs pathways. Video: https://medicaldigest.org/scientific-contents/interview:aymara-gene-tale-high-a...

Aaron Gerds, MD, MS discusses the state of the art treatment in polycythemia vera at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-polycythemia-vera

Aaron Gerds, MD, MS discusses the state of the art treatment in myelofibrosis at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-myelofibrosis

Cho Han Chiang, MD, MMSc presented an analysis at the 2024 ASH Annual Meeting, that shows GLP-1 receptor agonists led to a significant reduction in the risk for VTE among individuals with type 2 diabetes, compared with DPP-4 inhibitors, a recent indicated. Video: https://medicaldigest.org/scientific-contents/interview:do-glp-1s-lower-vte-risk-people-type-2-diabetes

Rahul Banerjee, MD, FACP comments on the role of 24-hour urine testing in assessing multiple myeloma treatment responses at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:24-hour-urine-testing-does-not-add-value-multiple-myeloma-response-assessments

Rahul Banerjee, MD, FACP discusses the state of the art treatment in Multiple Myeloma Care at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:bridging-gaps-multiple-myeloma-care-community-oncologists-guide-navigating-evolving-treatment-landscape

Matthew S. Davids, MD, MMSc discusses the state of the art treatment in chronic lymphocytic leukemia at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:crafting-custom-care-cll-guidance-upfront-and-sequential-treatment-decisions-targeted-and-immune-base-platforms

Anand A. Patel, MD discusses the state of the art treatment in adult acute lymphoblastic leukemia at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-adult-all

Catherine S. Diefenbach, MD discusses the state of the art treatment in lymphoma care at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-lymphoma

Prof. Francesco Passamonti discusses the state of the art treatment in myelofibrosis Care at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:mastering-art-myelofibrosis-care-expert-guidance-clinical-experience-innovation-more-personalized-disease-control

Kerry A Rogers, MD discusses current questions and controversies in the management of chronic lymphocytic leukemia at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:addressing-current-questions-and-controversies-management-chronic-lymphocytic-leukemia

Michael J. Mauro, MD discusses current questions and controversies in the management of chronic myeloid leukemia at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:addressing-current-questions-and-controversies-management-chronic-myeloid-leukemia

Mikkael A. Sekeres, MD, MS discusses the state of the art treatment in MDS at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-myelodysplastic-syndromes

Prof. Gilles Salles presented a 5-year analysis of the POLARIX study at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:five-year-analysis-polarix-study

Prof. Gilles Salles discusses managing first relapse in diffuse large B-Cell lymphoma outside of CAR-Ts at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:managing-first-relapse-diffuse-large-b-cell-lymphoma-outside-car-ts

Vaishali Sanchorawala, MD review the clinical challenges and intricacies of care associated with the management of light chain amyloidosis. Video: https://medicaldigest.org/scientific-contents/interview:unraveling-data-and-care-strategies-al-amyloidosis